Trinity Biotech plc (TRIB) — Long-term Investment Intensity
Trinity Biotech plc (TRIB) has a Long-term Investment Intensity of 2.4% as of December 2024. Long-term investments of $2.46 Million represent 2.4% of total assets of $103.29 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of Trinity Biotech plc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Trinity Biotech plc Long-term Investment Intensity (2014–2024)
This chart shows how Trinity Biotech plc's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2024. As of December 2024, the intensity stands at 2.4%, reflecting long-term investments of $2.46 Million against total assets of $103.29 Million USD. Also explore Trinity Biotech plc asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Trinity Biotech plc (2014–2024)
The table below presents the year-by-year Long-term Investment Intensity for Trinity Biotech plc from 2014 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see TRIB company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 2.4% | $2.46 Million | $103.29 Million | ▲ +2.2 pp |
| 2017 | 0.2% | $360.00K | $192.62 Million | ▼ -1.1 pp |
| 2015 | 1.3% | $4.69 Million | $358.96 Million | ▼ -0.6 pp |
| 2014 | 1.9% | $4.69 Million | $242.84 Million | — |